Beacon Pharmaceuticals PLC (DSE:BEACONPHAR)
Bangladesh
· Delayed Price · Currency is BDT 104.00
+3.80 (3.79%)
At close: Apr 28, 2026
Beacon Pharmaceuticals Revenue
Beacon Pharmaceuticals had revenue of 4.13B BDT in the quarter ending December 31, 2025, with 29.92% growth. This brings the company's revenue in the last twelve months to 14.78B, up 27.69% year-over-year. In the fiscal year ending June 30, 2025, Beacon Pharmaceuticals had annual revenue of 12.54B with 17.20% growth.
Revenue (ttm)
14.78B
Revenue Growth
+27.69%
P/S Ratio
1.62
Revenue / Employee
3.10M
Employees
4,771
Market Cap
24.02B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 12.54B | 1.84B | 17.20% |
| Jun 30, 2024 | 10.70B | 2.19B | 25.76% |
| Jun 30, 2023 | 8.51B | 487.21M | 6.07% |
| Jun 30, 2022 | 8.02B | 901.58M | 12.66% |
| Jun 30, 2021 | 7.12B | 1.53B | 27.37% |
| Jun 30, 2020 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| The ACME Laboratories | 38.86B |
| Unilever Consumer Care | 3.63B |
| Asiatic Laboratories | 2.24B |
| Renata | 44.26B |
| Beximco Pharmaceuticals PLC. | 46.34B |
| The IBN SINA Pharmaceutical Industry | 13.42B |
| Navana Pharmaceuticals | 10.07B |
| Orion Pharma | 3.12B |